Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

5.12
Delayed Data
As of Feb 16
 -0.06 / -1.16%
Today’s Change
3.88
Today|||52-Week Range
9.40
+10.82%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close5.18
Today’s open5.17
Day’s range5.09 - 5.35
Volume313,300
Average volume (3 months)368,957
Market cap$153.6M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-0.77%
Earnings growth (this year)+50.38%
Earnings growth (next 5 years)+74.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.38
Price/Book6.14

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...0.000.00%
ALRNAileron Therapeutics...-0.19-2.39%
ADMPAdamis Pharmaceutica...+0.28+9.40%
OCXOncoCyte Corp+0.05+1.43%
Data as of 8:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 15, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$799.0K
Annual profit (last year)-$29.7M
Net profit margin-3,721.12%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Executive VP, Chief Operating &
Financial Officer
Keith W. Marshall
Corporate headquarters
San Diego, California

Forecasts